amb, I just spent a little more time researching they haven't completed any phase three trials there latest ASX release goes like this -
Medlab (ASX:MDC) receives UK Ethics favourable
opinion for upcoming NanaBis™ P3 Trial.
An important step in the NanaBis™ Drug Application.
(Also to note they only got phase three approval for this in Australia in August last year, they haven't even started recruiting.)
This is the only phase three on the companies records. Can you actually back your comment with some articles or ASX releases, to show you didn't just make it up. It would be appreciated.
amb, I just spent a little more time researching they haven't...
Add CAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.12M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| CAN (ASX) Chart |
Day chart unavailable